Literature DB >> 6129918

Inhibitory cardiovascular function of neurons in the caudal ventrolateral medulla of the rabbit: relationship to the area containing A1 noradrenergic cells.

W W Blessing, D J Reis.   

Abstract

Experiments were performed to test the hypothesis that A1 noradrenergic neurons, in the caudal ventrolateral medulla, have an inhibitory cardiovascular function. The lateral portion of the caudal medulla was systematically explored, using focal electrical stimulation, in anesthetized, paralyzed rabbits and arterial pressure and heart rate responses were recorded. Since electrical stimulation activates fibers of passage as well as neuronal cell bodies, we also determined cardiovascular responses to microinjections of L-glutamate, a neuroexcitatory amino acid with minimum effects on fibers of passage. Histological studies of stimulation sites were combined with catecholamine fluorescence histochemical studies to localize the A1 cells. A decrease in arterial pressure and heart rate, restricted to the region containing A1 cells, was observed with low frequency stimulation and with microinjections of L-glutamate. In contrast, when GABA, an inhibitory amino acid, was microinjected into the A1 region, we observed an increase in arterial pressure and heart rate. L-Glutamate and GABA responses were dose-related. The fall in pressure was independent of the fall in heart rate. Results support our hypothesis, providing evidence that neurons in the A1 area tonically inhibit sympathetic vasomotor tone.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6129918     DOI: 10.1016/0006-8993(82)90683-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  Increase in the blood pressure and decrease in the norepinephrine release in the ventrolateral medulla during intraventricular administration of hypertonic NaCl.

Authors:  K Katahira; H Mikami; T Tsunetoshi; K Kohara; A Otsuka; M Nagano; T Ogihara
Journal:  Pflugers Arch       Date:  1989-09       Impact factor: 3.657

2.  Complete resolution of hypertension after decompression of Chiari I malformation.

Authors:  E C Parker; C Teo; S Rahman; M C Brodsky
Journal:  Skull Base Surg       Date:  2000

3.  Baroreceptor-vasomotor reflex after N-methyl-D-aspartate receptor blockade in rabbit caudal ventrolateral medulla.

Authors:  W W Blessing
Journal:  J Physiol       Date:  1989-09       Impact factor: 5.182

4.  A brainstem area mediating cerebrovascular and EEG responses to hypoxic excitation of rostral ventrolateral medulla in rat.

Authors:  E V Golanov; D A Ruggiero; D J Reis
Journal:  J Physiol       Date:  2000-12-01       Impact factor: 5.182

5.  Ipsilateral but not contralateral blockade of excitatory amino acid receptors in the caudal ventrolateral medulla inhibits aortic baroreceptor reflex in rats.

Authors:  T Kubo; M Kihara; Y Misu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-01       Impact factor: 3.000

Review 6.  Congestive cardiac failure: central role of the arterial blood pressure.

Authors:  P Harris
Journal:  Br Heart J       Date:  1987-09

Review 7.  Anatomical observations of the caudal vestibulo-sympathetic pathway.

Authors:  Gay R Holstein; Giorgio P Martinelli; Victor L Friedrich
Journal:  J Vestib Res       Date:  2011       Impact factor: 2.435

8.  Excitatory amino acid receptors in the caudal ventrolateral medulla mediate a vagal cardiopulmonary reflex in the rat.

Authors:  A J Verberne; P M Beart; W J Louis
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

9.  Inhibiting the rabbit caudal ventrolateral medulla prevents baroreceptor-initiated secretion of vasopressin.

Authors:  W W Blessing; J O Willoughby
Journal:  J Physiol       Date:  1985-10       Impact factor: 5.182

10.  Blockade of excitatory amino acid receptors in the ventrolateral medulla does not abolish the cardiovascular actions of L-glutamate.

Authors:  Z J Gieroba; W W Blessing
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-01       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.